<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04222608</url>
  </required_header>
  <id_info>
    <org_study_id>BRAvAdO</org_study_id>
    <nct_id>NCT04222608</nct_id>
  </id_info>
  <brief_title>The BRAvAdO Registry</brief_title>
  <acronym>BRAvAdO</acronym>
  <official_title>BRAzilian Registry of Acute Coronary Syndrome in Oncologic Patients - The BRAvAdO Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Instituto do Cancer do Estado de São Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beneficência Portuguesa de São Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Instituto de Cardiologia do Rio Grande do Sul</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>InCor Heart Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Sao Paulo General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The BRAVADO Registry pretends to identify stratification, diagnosis, total atherosclerotic
      burden and treatment approaches in oncologic patients with Acute Coronary Syndrome (ACS) and
      identify strategies to improve health care quality
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2016</start_date>
  <completion_date type="Anticipated">September 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>4 Years</target_duration>
  <primary_outcome>
    <measure>Major adverse cardiovascular events</measure>
    <time_frame>30 days</time_frame>
    <description>Composite endpoint of All-cause Death, Myocardial Infarction, Stroke and Myocardial Revascularization</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total Atherosclerotic burden and lesion complexity on angiography</measure>
    <time_frame>30 days</time_frame>
    <description>The number and location of coronary lesions with obstructions greater than 50% were recorded. Each lesion was classified based on Ambrose's, Goldstein complexity, Leaman and SYNTAX scores.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of Major Bleeding</measure>
    <time_frame>30 days</time_frame>
    <description>Requiring a transfusion of ≥2 U PRBCs Resulting in a decrease in hematocrit of ≥10% Occurring intracerebrally Resulting in stroke or death</description>
  </primary_outcome>
  <enrollment type="Anticipated">600</enrollment>
  <condition>ACS - Acute Coronary Syndrome</condition>
  <condition>Oncology</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Cancer patients with Acute Coronary Syndrome (ACS)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Definitive cancer diagnosis - biopsy

          -  Acute Coronary Syndrome - requiring urgent invasive risk stratification

        Exclusion Criteria:

          -  KPS &lt; 60 , ECOG &gt;/ 3

          -  Life expectancy less 24hs

          -  End of Life Care

          -  Lack of consistent record data
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Carlos M Campos</name>
      <address>
        <city>São Paulo</city>
        <zip>05403-900</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CARLOS M CAMPOS, PhD</last_name>
      <phone>+55 11 2661 5286</phone>
      <email>carlosacampos1@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Ludhmila A Hajjar, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 13, 2019</study_first_submitted>
  <study_first_submitted_qc>January 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 10, 2020</study_first_posted>
  <last_update_submitted>January 6, 2020</last_update_submitted>
  <last_update_submitted_qc>January 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cardio-Oncology</keyword>
  <keyword>Interventional Cardiology</keyword>
  <keyword>Cancer</keyword>
  <keyword>Oncology</keyword>
  <keyword>Acute Coronary Syndrome</keyword>
  <keyword>Myocardial Infarction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

